Transition of patients with childhood onset epilepsy: Perspectives from pediatric and adult neurologists.


Journal

Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858

Informations de publication

Date de publication:
03 2020
Historique:
received: 04 11 2019
revised: 22 12 2019
accepted: 22 12 2019
pubmed: 7 2 2020
medline: 24 11 2020
entrez: 7 2 2020
Statut: ppublish

Résumé

Transition from pediatric to adult care systems is a major challenge in the management of adolescents with epilepsy. The comparison of pediatric and adult physicians' points of view on this issue is scarcely described. The aim of this study was to understand pediatric and adult neurologists' experience and opinions on transition in epilepsy in France. We investigate the age at which they usually transfer patients, their opinion on the factors that positively or negatively impact transition, on the help provided during this transition period, and their propositions to improve this process. We prepared a targeted questionnaire with two versions, one adapted for neurologists and the other for child neurologists. The questionnaires were diffused through the Reference Centre for Rare Epilepsies, the French Chapter of the League Against Epilepsy, the French Association for Office-based Neurologists, and the French Pediatric Neurology Society. A total of sixty-eight physicians involved mostly in epilepsy care answered this questionnaire: 39 child neurologists and 29 neurologists. Questionnaires were filled at 96.8%. Twenty-six child neurologists followed patients aged over 18 years (70%), and 18 neurologists followed patients under the age of 12 years (66.6%). Cognitive impairment in childhood led significantly to a later transfer to adult care. The major factors believed to delay the transfer were attachment between child neurologists and families as reported in 96.3% by neurologists and in 81.1% by child neurologists, p = 0.07 and lack of adaptation of adult neurology facilities to adolescents especially with intellectual disability (59.3% neurologists, 75.7% child neurologists, p = 0.16). Factors that helped a transfer around 18-19 years were mainly pharmacoresistant epilepsy (71% for neurologists vs. 19% for child neurologists, p < 10

Identifiants

pubmed: 32028125
pii: S1525-5050(19)31199-0
doi: 10.1016/j.yebeh.2019.106889
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106889

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Rima Nabbout (R)

Reference Centre for Rare Epilepsies, Department of Pediatric Neurology, Necker-Enfants Malades Hospital, APHP, Paris Descartes University, Paris, France; Institut Imagine, INSERM UMR 1163, Translational Research for Neurological Disorder, Paris Descartes University, France. Electronic address: rima.nabbout@aphp.fr.

Theo Teng (T)

Reference Centre for Rare Epilepsies, Department of Pediatric Neurology, Necker-Enfants Malades Hospital, APHP, Paris Descartes University, Paris, France.

Nicole Chemaly (N)

Reference Centre for Rare Epilepsies, Department of Pediatric Neurology, Necker-Enfants Malades Hospital, APHP, Paris Descartes University, Paris, France; Institut Imagine, INSERM UMR 1163, Translational Research for Neurological Disorder, Paris Descartes University, France.

Delphine Breuillard (D)

Reference Centre for Rare Epilepsies, Department of Pediatric Neurology, Necker-Enfants Malades Hospital, APHP, Paris Descartes University, Paris, France.

Mathieu Kuchenbuch (M)

Reference Centre for Rare Epilepsies, Department of Pediatric Neurology, Necker-Enfants Malades Hospital, APHP, Paris Descartes University, Paris, France; Institut Imagine, INSERM UMR 1163, Translational Research for Neurological Disorder, Paris Descartes University, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH